Boraginaceae cynoglossum plant and new application of extractive thereof

A technology of Glazed Grass and Boraginaceae, applied in the field of medicine, can solve problems such as adverse reactions, blindness, and high financial burden for patients

Inactive Publication Date: 2016-03-16
赵明生
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Laser therapy and photodynamic therapy can only seal the existing new blood vessels, but cannot prevent the formation of new new blood vessels, so it is only a symptomatic treatment
These treatments are not only expensive, but also often require multiple operations depending on the condition, which is a high financial burden for patients
Anti-vascular endothelial growth factor (VEGF) biological agent therapy has many shortcomings or defects: 1) It can only control the development of the disease, but cannot change the pathological damage that has been caused
2) Unstable efficacy, unsatisfactory clinical expectations, high recurrence rate, and certain adverse reactions and risks
For example, the curative effect of ranibizumab gradually fades in the later

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] The preparation of embodiment 1 tablet of the present invention

[0048] Take 500 grams of Boraginaceae Glacis, soak in water for 1 hour according to 15 times the amount of the drug, put it in a decoction tank for 1 hour, filter out the drug solution, add 10 times the amount of water to decoct for 1 hour, filter out the drug solution, and combine Twice the medicinal solution, dehydrated and concentrated to a thick paste, add 20% soluble starch dextrin (or add the same amount of 200 mesh crude drug powder), mix well, dry at 60°C, pulverize, add 1% magnesium stearate and mix well, Sieve through a 20-mesh sieve for granulation, and press into tablets with a weight of 0.5 grams. Dosage: 2-3 tablets each time, three times a day.

Embodiment 2

[0049] The preparation of embodiment 2 tea preparations of the present invention

[0050] 1) Take 1 kg of Bordaceae Glacis, crush them together, pass through a 60-100 mesh sieve, and pack 4 grams per bag with filter paper on a tea bag machine to make tea in bags. How to take it: three times a day, 2-3 bags each time, put the medicine bag into a thermos cup each time, soak it in boiling water for about 2 hours and drink it, and then refill the water 1-2 times. This tea bag is sweet and delicious, and can be drunk all year round.

[0051] 2) Take 500 grams of Boraginaceae Glacis, soak in water for 1 hour according to 10 times the amount of the drug, put it in a decoction pot for 1 hour, filter out the medicinal liquid, add 10 times the amount of water to decoct for 1 hour, and filter out the medicinal liquid , combine the two liquid medicines, dehydrate and concentrate to a thick paste, add dextrin, dry at 60°C, pulverize, granulate, and make granules according to the amount of...

Embodiment 3

[0052] The preparation of embodiment 3 decoction of the present invention

[0053] Take 30-50 grams of Boraginaceae Glacis, add about 10 times of water, soak for 1 hour, put it into a decoction tank, boil the water for 30 minutes, pour out the liquid medicine, add 10 times of water, and fry for 30 minutes. Combine the two decoctions and take it three times in the morning, noon and night.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of medicine, and relates to a boraginaceae cynoglossum plant and new application of extractive thereof, in particular to the Boraginaceae cynoglossum plant and the application of the extractive of the Boraginaceae cynoglossum plant in preparation of medicine treating fundus maculopathy, wherein fundus maculopathy includes central exudative chorioretinopathy, central serous chorioretinopathy, senile macular degeneration, diabetic fundus macular degeneration, hypertensive macular degeneration and the like. Preparations prepared from the boraginaceae cynoglossum plant and the extractive of the boraginaceae cynoglossum plant serving as active ingredients have remarkable curative effects on fundus maculopathy and are safe and free of side effects. The boraginaceae cynoglossum plant belongs to a natural medicinal material and is wide in source, so that a novel choice is provided for treating the diseases clinically.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a new application of a plant of the genus Glaucoma of the family Boraginaceae and an extract thereof. Background technique [0002] The fundus is composed of the retina, fundus blood vessels, optic nerve head, optic nerve fibers, macula on the retina, and choroid behind the retina. The lesions in these parts are collectively called fundus diseases. The "macula" is a normal physiological area on the retina of the fundus, located in the center of the retina, where a large number of visual function cells are concentrated, and can recognize most optical signals such as shape, size, color, depth, distance, etc., and is an important part that determines visual function. [0003] Fundus macular degeneration is a common disease that affects the macula in middle-aged and elderly people. Blindness causes great distress to the life and physical and mental health of middle-aged and elder...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/30A61P27/02
CPCA61K36/30A61K9/0019A61K9/0048A61K9/0095A61K9/08A61K9/2059A61K9/4808A61K2300/00
Inventor 赵明生
Owner 赵明生
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap